Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 204082
Company: WEST-WARD PHARMS INT
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription AB No No
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 25MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/16/2016 ORIG-1 Approval Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204082Orig1s000ltr.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/05/2017 SUPPL-3 Labeling-Package Insert

Label is not available on this site.

11/15/2016 SUPPL-2 Labeling-Package Insert

Label is not available on this site.

DESVENLAFAXINE SUCCINATE

TABLET, EXTENDED RELEASE;ORAL; EQ 50MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204065 ACTAVIS LABS FL
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204003 ALEMBIC PHARMS LTD
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204028 CASI PHARMS INC
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204805 INTELLIPHARMACEUTICS
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204172 LUPIN LTD
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204095 MYLAN
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204082 WEST-WARD PHARMS INT
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204020 ZYDUS PHARMS
PRISTIQ DESVENLAFAXINE SUCCINATE EQ 50MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription Yes AB 021992 PF PRISM CV

TABLET, EXTENDED RELEASE;ORAL; EQ 25MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 25MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204065 ACTAVIS LABS FL
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 25MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204003 ALEMBIC PHARMS LTD
DESVENLAFAXINE SUCCINATE DESVENLAFAXINE SUCCINATE EQ 25MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription No AB 204082 WEST-WARD PHARMS INT
PRISTIQ DESVENLAFAXINE SUCCINATE EQ 25MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription Yes AB 021992 PF PRISM CV

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English